Isabelle André-Schmutz

9PUBLICATIONS
190CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 16, 2026
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Taja Vatovec, Anna-Lena Neehus, Katherine J L Jackson

|Nov 19, 2024
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.

Elena Blanco, Carme Camps, Sameer Bahal

|Mar 14, 2023
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.

Romane Thouenon, Loïc Chentout, Nidia Moreno-Corona

|Nov 14, 2022
Author Correction to: T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all.

P Gaudeaux, R D Moirangthem, J Paillet

|Sep 30, 2022
T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all.

P Gaudeaux, R D Moirangthem, J Paillet

Pageof 2